Back
Structure Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison
Buy
71
GPCR
Structure Therapeutics
Last Price:
41.65
Seasonality Move:
4.68%
Sell
38
NVO
Novo Nordisk AS
Last Price:
120.88
Seasonality Move:
5.6%
Buy
71
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $41.75. The Score for GPCR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GPCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $120.76. The Score for NVO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $41.75
The current trend is moderately bullish and GPCR is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $120.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
GPCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.05 | Buy |
Relative Strength Index (14 RSI): | 56.84 | Buy |
Chaikin Money Flow: | 9293 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.34 - 41.7) | Buy |
Bollinger Bands (100): | (34.82 - 45.26) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.68 | Sell |
Relative Strength Index (14 RSI): | 34.72 | Sell |
Chaikin Money Flow: | 4535394 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (127.38 - 137.14) | Sell |
Bollinger Bands (100): | (129.17 - 140.83) | Sell |
GPCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.32 | Buy |
20-day SMA: | 39.44 | Buy |
50-day SMA: | 38.13 | Buy |
200-day SMA: | 40.73 | Buy |
8-day EMA: | 41.37 | Buy |
20-day EMA: | 40.15 | Buy |
50-day EMA: | 39.42 | Buy |
200-day EMA: | 39.76 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.95 | Sell |
20-day SMA: | 131.35 | Sell |
50-day SMA: | 131.82 | Sell |
200-day SMA: | 126.68 | Sell |
8-day EMA: | 126.32 | Sell |
20-day EMA: | 129.82 | Sell |
50-day EMA: | 132.23 | Sell |
200-day EMA: | 124.85 | Sell |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.92 per share.
Structure Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |